null

Ryan White Clinics for 340B Access aspires to protect and preserve the 340B Drug Pricing Program through advocacy and education to ensure members can continue to provide high-quality care to their patients.

The Federal 340B Drug Pricing Program is a federal program established in 1992 that requires drug manufacturers to provide outpatient drugs to eligible health care organizations and covered entities at significantly discounted rates.

RWC-340B is committed to protecting and preserving the 340B Drug Pricing Program.

Stop Drug Manufacturers from Undermining Our Use of the 340B Program

Ryan White Clinics Call on Congress, HHS, & HRSA to Stop Drug Manufacturers from Undermining Our Use of the 340B Program to Care for People with HIV.

Discriminatory reimbursement is contrary to the purpose of the 340B program

As the legislative history of the 340B statute makes clear, the purpose of giving qualified safety net providers access to 340B pricing is to enable them to stretch their scarce resources.

Ryan White Clinics Endorse McKinley-Spanberger Legislation to Prohibit Discrimination Against 340B Safety Net Providers, Protect Program Integrity

This bipartisan bill seeks to prevent pharmacy benefit managers and other third-party payers from paying below-market rates or engaging in other discriminatory contracting practices that undermine participation in the 340B Program by Ryan White clinics, federally qualified health centers and other safety net providers.

The members of RWC-340B believe in the power of the many.
Working together we can have a more substantial and lasting impact than we could apart.

Member Benefits

Benefactor Benefits

340B Events

Important News & Updates